Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fabino EnterprisesBOM:543444 68 Days Payable is 151.53 as of Mar. 2026, which is 0% below its 10-year median of 151.89. GuruFocus rates BOM:543444 with a GF Score™ of 68/100 and a GF Value™ of ₹37.57. The stock has 5 warning signs investors should review. Among 926 Drug Manufacturers companies, Fabino Enterprises ranks better than 86.18% on this metric.
The historical rank and industry rank for Fabino Enterprises's Days Payable or its related term are showing as below:
BOM:543444'
s Days Payable Range Over the Past 10 Years
Min: 41.96 Med: 151.89 Max: 1009.13
Current: 210.84
During the past 8 years, Fabino Enterprises's highest Days Payable was 1009.13. The lowest was 41.96. And the median was 151.89.
BOM:543444's Days Payable is ranked better than 86.18% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs BOM:543444: 210.84
Fabino Enterprises's Days Payable
declined
from Mar. 2025 (172.25) to Mar. 2026 (151.53).
It may suggest that Fabino Enterprisesaccelerated paying its suppliers.
Fabino Enterprises Days Payable Related Terms
Fabino Enterprises Days Payable Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's Days Payable distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Fabino Enterprises's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a Days Payable of 151.53 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fabino Enterprises and its competitors. This is near median its historical median of 151.89. Over the past decade, Fabino Enterprises' Days Payable has ranged from 41.96 to 1,009.13. According to the industry distribution chart, Fabino Enterprises ranks #128 out of 926 companies in the Drug Manufacturers industry, placing it in the top 13.8%.
Is Fabino Enterprises' Days Payable too high?
Fabino Enterprises' current Days Payable of 151.53 is near median its 10-year median of 151.89. Over the past 10 years, this metric has ranged from a low of 41.96 to a high of 1,009.13. The Drug Manufacturers industry median Days Payable is 90.22. Fabino Enterprises' value of 151.53 is 68% above this industry median. Based on the distribution chart, Fabino Enterprises ranks #128 out of 926 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fabino Enterprises ranks #128 out of 926 companies for Days Payable. This places Fabino Enterprises in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.22. Fabino Enterprises' value of 151.53 is 68% above this benchmark. Historically, Fabino Enterprises' own Days Payable has ranged from 41.96 to 1,009.13 over the past decade. While the company's 10-year median is 151.89 vs. the industry median of 90.22, Fabino Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current Days Payable of 151.53 is 68% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current Days Payable is 151.53, which is near median its own 10-year median of 151.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current Days Payable of 151.53. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current Days Payable is 151.53, which is near median its 10-year median of 151.89 and 68% above the Drug Manufacturers industry median of 90.22. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current Days Payable is 151.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
Days Payable: 151.53 (near median its 10-year median of 151.89)
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 68% above the Drug Manufacturers median (#128 of 926)
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
